TD Cowen downgraded Procter & Gamble to Hold from Buy with a price target of $156, up from $150. The firm says the pace of the company’s recovery is “likely to drag.” Bulls owns the shares on the assumption that Procter’s organic sales growth bottomed in Q2 of 2025 at 0% and will accelerate on easier compares and a recovery in market share, the analyst tells investors in a research note. However, TD believes Procter’s growth will “remain subdued” at 2% over the next two years on a lack of pricing power and pressure on the Hispanic consumer.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble: Solid Fundamentals but Limited Near-Term Upside Support a Hold Rating
- P&G Insiders Make No New 10b5-1 Trading Plans in Q4 2025, Signaling Stability but Limiting Transparency
- Palantir, Micron, Starbucks, Alphabet, P&G Trending With Analysts
- Midday Fly By: TikTok forms U.S. JV, Intel guidance underwhelms
- Darden upgraded, Trade Desk downgraded: Wall Street’s top analyst calls